Article Figures & Tables
Figures
Figure 1: Cost-effectiveness acceptability curves for different prices per blood glucose test strip. These curves show the probability that performing self-monitoring of blood glucose (SMBG) is cost-effective relative to not performing self-monitoring in patients with type 2 diabetes who are not using insulin, across a range of decision-makers’ willingness to pay-thresholds.
Figure 2: Cost-effectiveness acceptability curves for 2-way sensitivity analyses, in which HbA1C estimates of effect and self-monitoring of blood glucose (SMBG) testing frequencies were both varied.
Tables
Table 1: Modelled management costs and utility decrements
Table 2: Cumulative incidence of diabetes-related complications over a 40-year period among patients with type 2 diabetes who do not use insulin who self-monitor their blood glucose levels and those who do not self-monitor
Table 3: Benefits, costs and incremental cost utility ratios for self-monitoring blood glucose levels among patients with type 2 diabetes not using insulin*
Table 4: Incremental cost-utility ratios for the comparison of self-monitoring of blood glucose with no self-monitoring in patients with type 2 diabetes not using insulin
In this issue
Article tools
Jump to section
Related Articles
Cited By...
- Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008?
- Reduction in self-monitoring of blood glucose in type 2 diabetes: an observational controlled study in east London
- Approach to economic evaluation in primary care: Review of a useful tool for primary care reform
- Self-Monitoring of Blood Glucose in Noninsulin-Using Type 2 Diabetic Patients: It is time to face the evidence
- Routine self-monitoring of blood glucose
- Daily self-monitoring unlikely to be cost-effective in adults with type 2 diabetes not using insulin in Canada
- The author responds:
- Missing the boat
More in this TOC Section
Similar Articles
